BREAKING NEWS… Chimeric licenses novel solid tumor CAR T therapy from world renowned Cell Therapy Centre University of Pennsylvania

Chimeric Therapeutics

Chimeric Therapeutics is a clinical stage cell therapy company focused on bringing the promise of cell therapy to life for more patients with cancer. We believe that cellular therapies have the promise to cure cancer not just delay disease progression

To bring that promise to life for more patients, Chimeric’s world class team of cell therapy pioneers and experts is focused on the discovery, development and commercialisation of the most innovative and promising cell therapies

To learn more about Chimeric’s new CDH17 CAR T